GRI•benzinga•
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $34
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 27, 2025 by benzinga